1-5 of 5
Majid Kazmi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Mobilization, Harvest, and Transplant Outcomes in Newly Diagnosed Multiple Myeloma Patients Receiving D-VTd: A UK Centre Experience

Christianne Bourlon, Katharine Elizabeth Bailey, Reuben Benjamin, Kirsty Cuthill, Arief Gunawan, Majid Kazmi, Pramila Krishnamurthy, Victoria Potter, Robin Sanderson, Michelle Kenyon, Mili Shah, Matthew Streetly, Fabio Serpenti, Stella J. Bowcock, Lalita Banerjee, John Robert Jones, Sabia Rashid, Ana Isabel Duran Maestre, Satyajit Sahu, Sudarshan Gurung, Lianwea Chia, Haili Cui, Alison Pratt, Maheen Ahsan, Stella Bouziana
Journal: Blood
Blood (2023) 142 (Supplement 1): 4971.
https://doi.org/10.1182/blood-2023-177624
Published: 2023
Journal Articles

Thalidomide in Haematology Practice at an UK District General Hospital - A 6 Year Experience.

Anil V. Kamat, MBBS, MRCP, Raphael Ezekwesili, MBBS,FRCP,FRCPath, Majid Kazmi, MBBS,FRCP,FRCPath
Journal: Blood
Blood (2006) 108 (11): 5511.
https://doi.org/10.1182/blood.V108.11.5511.5511
Published: 2006
Journal Articles

The Thalidomide Analogue (Actimid) Induces T-Cell Activation at Day 28 in Patients with Relapsed Refractory Myeloma but Does Not Correlate with Improved Outcome.

Gulrukh Ahsan, MSc, Mathew Streetly, MD, Paul A. Fields, MD, PhD, Auther R. Bradwell, PhD, Steve A. Schey, MD, Majid Kazmi, MD
Journal: Blood
Blood (2005) 106 (11): 3473.
https://doi.org/10.1182/blood.V106.11.3473.3473
Published: 2005
Journal Articles

B Cell Post Transplant Lymphoproliferative Disorder Complicating Solid Organ Transplantation (B-PTLD): A Single Centre Review Reporting 1) Results with Chemo-Immunotherapy (CHOP/R) and 2) the Predictive Ability of FDG-PET Scanning To Correlate with Long Term Overall Survival.

Sameer Tulpule, MD, George Mikhaeel, MD, Majid Kazmi, MD, Tom Nunan, MD, John Van Der Walt, MD, David Goldsmith, MD, Paul A. Fields, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 1500.
https://doi.org/10.1182/blood.V106.11.1500.1500
Published: 2005
Journal Articles

Alternate Day Actimid™ (CC-4047) Is Well Tolerated and Is Active When Used to Treat Relapsed/Refractory Myeloma.

Matthew Streetly, BM, BS, Kylie Gyertson, Majid Kazmi, Jerome Zeldis, Steve A. Schey
Journal: Blood
Blood (2004) 104 (11): 332.
https://doi.org/10.1182/blood.V104.11.332.332
Published: 2004